Document is current
Any future updates will be listed below
-
Authors
Brown, Carolyn
Kang, Hyeun Ah
Johnsrud, Michael
Terry, Jamie
Doshi, Gury
Broussard, Stephanie
Orji, Chinelo
-
Funding
Funding for this research was provided by:
Conquer Cancer®, the ASCO Foundation and Pfizer Global Medical Grants (FA00000723)
- License Information
-
More Information
Article History
Received: 17 November 2024
Accepted: 16 April 2025
First Online: 12 May 2025
Declarations
:
: The study was approved by the University of Texas at Austin Institutional Review Board (IRB) (ID: STUDY00002132). The IRB determined that the proposed activity is not research involving human subjects as defined by U.S. Department of Health and Human Services (DHHS) and Food and Drug Administration (FDA) regulations. The activity was determined to be Non-Human Subjects Research. The need for informed consent to participate was waived by the University of Texas at Austin IRB.
: Not applicable. Only aggregated data and/or results are shown in this manuscript.
: The authors declare no competing interests. At the time of the study, Dr. Broussard was an employee of Texas Oncology Network and Dr. Orji was a doctoral student at the University of Texas at Austin.
